Drug intelligence / Profile preview

butorphanol

Development stage
Approved
Lead developer
Bristol Myers Squibb
Modality
Small Molecules
Administration
Intranasal, Intravenous, Intramuscular
01

Overview

Butorphanol is a synthetic opioid analgesic classified as an opioid agonist-antagonist. It is primarily used to manage moderate to severe pain in humans and animals. Butorphanol acts as a partial agonist at the mu-opioid receptor and a full agonist at the kappa-opioid receptor, resulting in analgesia by altering pain perception within the central nervous system. Its unique pharmacological profile allows it to provide pain relief while also antagonizing some effects of pure mu-opioid agonists like morphine. Butorphanol is available in several formulations including nasal spray and injectable solutions; it can be administered intravenously, intramuscularly, or via nasal spray. In addition to its use for general pain management, it may be used during labor or surgery and has veterinary applications as an analgesic and antitussive[1][2][3][4][5][7].

Brand names
StadolTorbutrolTorbugesicDolorex
Other names
butorphanol tartrate
02

Targets

KOR (Kappa opioid receptor)DOR (Opioid Receptor Delta 1)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on butorphanol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on butorphanol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call